Laboratory for Molecular Reproduction and Genetics, Department of Anatomy, All India Institute of Medical Sciences, New Delhi, India.
Department of Rheumatology, All India Institute of Medical Sciences, New Delhi, India.
Immunol Invest. 2020 Feb;49(1-2):88-105. doi: 10.1080/08820139.2019.1657146. Epub 2019 Sep 5.
: Human leukocyte antigen (HLA)-G antigens are inducible non-classical major histocompatibility complex class Ib molecules which play an important role in the regulation of inflammatory processes and immunomodulation in autoimmune diseases. There are controversial reports on the impact of gene polymorphisms on rheumatoid arthritis (RA). This study aimed at examining the impact of 14 base pair (bp) ins/del (rs66554220) and +3142G>C (rs1063320) polymorphisms and correlating these with soluble HLA-G (sHLA-G) levels to understand the susceptibility to RA in our sample cohort.: Genomic DNA from 140 RA patients and 125 healthy controls was isolated using the salting out method. The genotyping of two polymorphisms of HLA-G (+3142G>C and 14 bp ins/del) was done by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) and PCR method, respectively. Levels of sHLA-G were estimated by ELISA and disease activity was calculated by disease activity score (DAS28-ESR).: The +3142G>C polymorphism was found to be associated with a decreased risk of RA as attributed to recessive inheritance tested model results (OR = 0.4, 95%C.I. = 0.2-0.9, = .0313*, GG + GC versus CC). Our finding did not support an association between 14 bp ins/del variant and risk/protection of RA. The sHLA-G levels were significantly lower in +3142GG and +3142GC RA patients as compared to healthy controls.: +3142G>C gene polymorphism might decrease the risk of occurrence of RA in our sample cohort as +3142CC genotype is associated with increased sHLA-G levels.: HLA-G: human leukocyte antigen-G; RA: rheumatoid arthritis; MHC: major histocompatibility complex; UTR: untranslated region; URR: upstream regulatory region; SLE: systemic lupus erythematous; PCR-RFLP: polymerase chain reaction restriction fragment length polymorphism; sHLA-G: soluble HLA-G; bp: base pair; ACR/EULAR: American College of Rheumatology/European League against Rheumatism; RF: rheumatoid factor; Anti-CCP: anti-cyclic citrullinated peptide; DAS28-ESR: Disease Activity Score 28- Erythrocyte Sedimentation Rate; TJC: tender joint count; SJC: swollen joint count; ESR: erythrocyte sedimentation rate; PGA: patient global assessment; HTN: hypertension; DM: diabetes mellitus; TB: tuberculosis; IEC: Institute Ethics Committee; ELISA: enzyme linked immunosorbent assay; ROC: receiver operating characteristics; AUC: area under curve; SNP: single nucleotide polymorphism; MTX: methotrexate; DMARDs: disease modifying anti-rheumatic drugs; Treg: regulatory T cells; IL: interleukin: soluble HLA-G: Units/mL {U/mL}.
人类白细胞抗原 (HLA)-G 抗原是诱导的非经典主要组织相容性复合体 Ib 分子,在自身免疫性疾病中的炎症过程调节和免疫调节中发挥重要作用。基因多态性对类风湿关节炎 (RA) 的影响存在争议报告。本研究旨在研究 14 个碱基对 (bp) 插入/缺失 (rs66554220) 和 +3142G>C(rs1063320) 多态性的影响,并将其与可溶性 HLA-G(sHLA-G) 水平相关联,以了解我们样本队列中对 RA 的易感性。
使用盐析法从 140 名 RA 患者和 125 名健康对照者中分离基因组 DNA。使用聚合酶链反应限制性片段长度多态性 (PCR-RFLP) 和 PCR 方法分别对 HLA-G 的两个多态性 (+3142G>C 和 14 bp ins/del) 进行基因分型。使用酶联免疫吸附试验 (ELISA) 估计 sHLA-G 水平,并通过疾病活动评分 (DAS28-ESR) 计算疾病活动度。
结果发现,+3142G>C 多态性与 RA 的风险降低相关,这归因于隐性遗传测试模型结果 (OR = 0.4,95%CI = 0.2-0.9, = 0.0313*, GG+GC 与 CC)。我们的发现不支持 14 bp ins/del 变异与 RA 的风险/保护之间的关联。与健康对照组相比,+3142GG 和 +3142GC RA 患者的 sHLA-G 水平显著降低。
+3142G>C 基因多态性可能降低了我们样本队列中 RA 的发生风险,因为 +3142CC 基因型与 sHLA-G 水平升高相关。
HLA-G:人类白细胞抗原-G;RA:类风湿关节炎;MHC:主要组织相容性复合体;UTR:非翻译区;URR:上游调节区;SLE:系统性红斑狼疮;PCR-RFLP:聚合酶链反应限制性片段长度多态性;sHLA-G:可溶性 HLA-G;bp:碱基对;ACR/EULAR:美国风湿病学会/欧洲抗风湿病联盟;RF:类风湿因子;抗-CCP:抗环瓜氨酸肽;DAS28-ESR:疾病活动评分 28-红细胞沉降率;TJC:压痛关节计数;SJC:肿胀关节计数;ESR:红细胞沉降率;PGA:患者总体评估;HTN:高血压;DM:糖尿病;TB:结核病;IEC:机构伦理委员会;ELISA:酶联免疫吸附试验;ROC:接收者操作特征;AUC:曲线下面积;SNP:单核苷酸多态性;MTX:甲氨蝶呤;DMARDs:改善病情的抗风湿药;Treg:调节性 T 细胞;IL:白细胞介素;sHLA-G:单位/mL(U/mL)。